HOME >> BIOLOGY >> NEWS
A sharper look at the brain

Thanks to a dramatic improvement in imaging techniques it is now possible to generate high-resolution pictures of the monkey brain in a quality never seen before. A research group led by neurophysiologist Prof. Nikos Logothetis of the Max Planck Institute for Biological Cybernetics and physician Prof. Dr. Heinz Guggenberger of the Eberhard Karl University (both in Tübingen, Germany) was the first ever to successfully use the so-called fMRI technique (from functional magnetic resonance imaging) to produce detailed pictures of active brain regions in monkeys which have been anesthetized but are still capable of perception (nature neuroscience, Vol. 2, No. 6, June 1999). Until now, many scientists were convinced that it would be impossible to gather such images from anesthetized monkeys.

The fMRI technique uses a strong magnetic field to detect brain regions which are active and thus more strongly perfused. It promises new impetus for the area of brain research. fMRI makes it possible to pinpoint the precise regions of the monkey's visual cortex (that region of the cerebral cortex responsible for sight) where optical stimuli are processed. The non-invasive measurements are carried out under anesthesia conditions that meet the most up-to-date standards in human clinical medicine. The eyelids are held open artificially so the animals can see the presented test pattern. At the same time, constant irrigation prevents any damage to the eyes. The monkey wakes up and is fully conscious an average of 15 minutes after the experiment. The new technique places much less strain on the animal than conventional methods and makes it unnecessary to put them to sleep after the experiment.

The improved method made it possible to visualize brain volumes as small as 0.5 microliters in anesthetized monkeys and 2 microliters in a control group of alert monkeys. (One microliter is one millionth of a liter.) This is the highest resolution ever achieved in pictures of the pri
'"/>

Contact: Nikos K. Logothetis
nikos.logothetis@tuebingen.mpg.de
49-70-71-6-01-6
Max-Planck-Gesellschaft
4-Jun-1999


Page: 1 2 3

Related biology news :

1. Gene chips bring new order to lung cancer types, could yield sharper diagnoses, better drugs
2. Trial shows which brain cancer patients benefit from temozolomide
3. Targeted therapy knocks out pediatric brain cancer in mice
4. New way to protect brain from stroke damage
5. Chemical signals health of brain cells Symposium
6. DHA-rich diet protects brain from Alzheimers damage, UCLA study shows
7. Decreasing toxins in brains of Alzheimers patients keep cognitive deficits at bay
8. Genetic clues found for common congenital brain disorder
9. Marijuana ingredient inhibits VEGF pathway required for brain tumor blood vessels
10. Molecular therapeutics advance fight against brain cancer
11. Depression traced to overactive brain circuit

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: sharper look the brain

(Date:10/15/2014)... the 44th Rosenstiel Award for Distinguished Work in Biomedical ... the mechanisms of genomic instability and its implications for ... second alumnus to win the Rosenstiel Award; the first, ... Alt is the Charles A. Janeway Professor of Pediatrics ... an investigator at the Howard Hughes Medical Institute at ...
(Date:10/14/2014)... shows SIRT6—a protein known to inhibit the growth ... skin cancers by turning on an enzyme that increases ... Previously considered protective, SIRT6 is part of a family ... stability and prevent some of the genetic flaws associated ... lead to cancer. This study, in the journal,s October ...
(Date:10/14/2014)... of the planet,s leading questions is how to produce ... variable climate. The Food and Agriculture Organization of the ... over the next 40 years to feed a growing ... the necessary rise in food production. Plants—grains, cereals, ... supporting livestock. Current research must tap into our ...
Breaking Biology News(10 mins):Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3
(Date:10/22/2014)... YORK , Oct. 22, 2014 Nuvilex, ... Federation, approximately 400 million people worldwide are living with ... million people by 2030.  The global market for diabetes ... 2012 approximately 330,000 people worldwide died from pancreatic cancer.  ... death due to cancer in the United ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... YORK , Oct. 20, 2014 ... their experimental ZMapp™ antibody therapeutic to fight the ... how difficult and time-consuming the production of pharmaceuticals ... market research publisher said that while some may ... of this compound, those with industry knowledge are ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: